戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -lactam antibiotics (amoxicillin, oxacillin, penicillin G).
2 re remains a national shortage of injectable penicillin G.
3  to day 7 after the first dose of benzathine penicillin G.
4 MIPs against Z-L-Phe, Z-L-glutamic acid, and penicillin G.
5 D)Ala-thioacetic acid [Bz-(D)Ala-(S)Gly] and penicillin G.
6 e does have a significant role in binding of penicillin G.
7 llin and, with the exception of two strains, penicillin G.
8 st-line treatment for syphilis is benzathine penicillin G.
9 ctances were reduced by picrotoxin, zinc, or penicillin-G.
10 PBP2a acylation reaction, the value of K(m) (penicillin G) = 0.5 +/- 0.1 mM and kcat = 1 x 10(-3) s-1
11 icipants received a first dose of benzathine penicillin G, 2.4 million units intramuscularly, at the
12  significant matrix effects, quantitation of penicillin G, a common antimicrobial, is possible in pla
13                                              Penicillin G, a transpeptidation inhibitor, had no effec
14 labile blocking group that can be removed by penicillin G acylase (PGA).
15                     The crystal structure of penicillin G acylase from Escherichia coli has been dete
16 y processing precursor mutant (Thr263Gly) of penicillin G acylase from Escherichia coli, which reveal
17 n G to 6-aminopenicillanic acid catalyzed by Penicillin G acylase in miniaturized stirred batch react
18                                              Penicillin G acylase is a periplasmic protein, cytoplasm
19                                We engineered penicillin G acylases to distinguish among free amino mo
20 mmended treatment for syphilis is benzathine penicillin G administered as intramuscular doses of 2.4
21 in control conditions and following systemic penicillin-G administration to adult cats.
22 or all stages of syphilis remains parenteral penicillin G, although the preparation, dose, route of a
23 pigrum isolates were in-vitro susceptible to penicillin G, amoxicillin, doxycycline, rifampicin and g
24 ventional beta-lactam antibiotics, including penicillin-G, amoxicillin, ampicillin, and cefazolin, ar
25 y 12 hours), meropenem, imipenem/cilastatin, penicillin G, ampicillin, ampicillin/sulbactam, doxycycl
26 uction of beta-lactamase was correlated with penicillin G, ampicillin, and ampicillin-sulbactam MICs
27 nst seven different beta-lactam antibiotics (penicillin G, ampicillin, cephalothin, cefaclor, cefurox
28 as the W82A mutant reduced ring-expansion of penicillin G (an "unnatural" substrate).
29 re approximately the same as K(m) values for penicillin G and ampicillin found in the literature (~30
30 tein PBP2X that conferred a 2-fold increased penicillin G and ampicillin MIC among the isolates teste
31 production correlated with susceptibility to penicillin G and ampicillin.
32 ctamase-negative strains were susceptible to penicillin G and ampicillin; all beta-lactamase-positive
33 ) pH dependencies for acylation of PBP 2x by penicillin G and Bz-(D)Ala-(S)Gly are identical, suggest
34 tant selectively catalyzed ring-expansion of penicillin G and had improved kinetic parameters (K(m) =
35 mined in its native form and in complex with penicillin G and penicillin G sulphoxide.
36 eractions of beta-lactam antibiotics such as penicillin-G and cefotaxime with normal, penicillin-susc
37 rate constants for the antibiotics imipenem, penicillin G, and ceftriaxone.
38 e, flutamide, flufenamic acid, the K salt of penicillin G, and form 4 of the drug 4-[4-(2-adamantylca
39 se in resistance to methicillin, cefotaxime, penicillin G, and nafcillin.
40 six antibiotics (clindamycin, ciprofloxacin, penicillin-G, and trimethoprim).
41 red-emitting dye with properly produced anti-penicillin G antibodies.
42 a serologic treatment response to benzathine penicillin G at 6 months was higher among participants w
43 cure rates for those treated with benzathine penicillin G at a dosage of 2.4 million units administer
44 mly assigned to receive either injections of penicillin G benzathine (also known as benzathine benzyl
45 nts for early syphilis: 2.4 million units of penicillin G benzathine and that therapy enhanced with a
46 tly recommended, single-dose alternatives to penicillin G benzathine are available for treatment of i
47 doubts about the adequacy of the recommended penicillin G benzathine therapy for early syphilis.
48 avuligerus NP1, we have been able to convert penicillin G (benzylpenicillin) to deacetoxycephalospori
49 mmend the use of a single dose of benzathine penicillin G (BPG) for treating early syphilis in human
50 .4 million units of intramuscular benzathine penicillin G (BPG) is recommended for the treatment of e
51                                   Benzathine penicillin G (BPG) is the only recommended treatment to
52                       Single-dose benzathine penicillin G (BPG) is the preferred therapy for early sy
53 ies; however, few receive optimal benzathine penicillin G (BPG) therapy to prevent disease progressio
54 (Delta310 mutant) enhanced ring-expansion of penicillin G by approximately 2-fold.
55  a significant role in the ring expansion of penicillin G by resting cells or cell-free extracts.
56                       AmpH bound strongly to penicillin G, cefoxitin, and cephalosporin C; was temper
57                 The proposed method is based penicillin G conjugate labeled with red-emitting dye wit
58 lin), sodium dodecyl sulfate (+control), and penicillin-G (-control).
59  The deacylation rate constant for the PBP2a-penicillin G covalent complex was found to be 5.7 +/- 1.
60 mainstay of syphilis treatment is parenteral penicillin G despite the relatively modest clinical tria
61 posure to 20 microg/ml (27 times the MIC) of penicillin G for 6 h and 24 h, respectively.
62 no clinical benefit to >1 dose of benzathine penicillin G for early syphilis in human immunodeficienc
63  orally was equivalent to that of benzathine penicillin G for the treatment of early syphilis in pers
64 vidence for a two-step acylation of PBP2x by penicillin-G has been demonstrated, and the dissociation
65 ceive intramuscular injections of benzathine penicillin G in a one-time dose of 2.4 million units or
66 tment efficacy of 1 vs 3 doses of benzathine penicillin G in adults with early syphilis, measured as
67  of early syphilis treatment wtih benzathine penicillin G in adults, approximately 1 in 4 participant
68 icillin determinants, all being positive for penicillin G in ICT.
69 rent analytical methods used to quantify the penicillin G in milk are based on HPLC, mass spectrometr
70                                 Detection of penicillin G in milk is of interest because of the wide
71 nsing approach for detecting the presence of penicillin G in milk.
72 ropriate duration of therapy with benzathine penicillin G in persons with early (i.e., primary, secon
73 ri is not eliminated by therapeutic doses of penicillin G; in contrast, doxycycline is effective.
74                                              Penicillin G, included in the endothelial cell growth me
75  industrially important metabolites urea and penicillin G is demonstrated.
76 ptomycin/ml of drinking water and 1,500 U of penicillin G/ml for 4 days and then ingested 10(7) CFU o
77 agents ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and
78             Increased resistance to BACs and penicillin G of the two BACs-exposed communities is pred
79 bolite of ceftiofur), ampicillin, cefazolin, penicillin G, oxacillin, cloxacillin, naficillin, and di
80 of streptomycin (SM), tetracycline (TC), and penicillin G (PC-G) in milk.
81        The main effector genes for producing penicillin G (pcbAB, pcbC and penDE) show amino acid div
82 iry and poultry is essential, especially for Penicillin-G (Pen-G), a frequently used beta-lactam anti
83 xtraction and detection of benzylpenicillin (penicillin G, PEN G).
84 ssociated with the rise of the resistance to penicillin G (PenG) in protein evolution from penicillin
85 were treated with either intravenous aqueous penicillin G (PenG) or intramuscular aqueous procaine pe
86 normalities treated with intravenous aqueous penicillin G (PenG) or intramuscular aqueous procaine pe
87        Here, using the classical beta-lactam penicillin G (PenG), we probe the B and T cell determina
88 parametric quantification of specific IgE to penicillin G, penicillin V, amoxicillin, and piperacilli
89 uscular injection with 66,000 IU of procaine penicillin G per kg of body weight on days 8 to 10 (grou
90                            Ampicillin (AMP), penicillin G (PG), penicillin V (PV), oxacillin (OXA), c
91 n G (PenG) or intramuscular aqueous procaine penicillin G plus oral probenecid (APPG-P) were evaluate
92 n G (PenG) or intramuscular aqueous procaine penicillin G plus oral probenecid (APPG-P).
93 nted polymer as a receptor (B/YCDs@mMIP) for penicillin-G (PNG) detection in milk.
94 lactams, such as cephalothin, meropenem, and penicillin G, proceed through an electronically similar
95 two separate models: one specific to inhibit penicillin G-reactive IgE and another to inhibit IgE spe
96  of clinical and soil-derived strains reveal penicillin G resistance in 2 to 16% of isolates tested.
97  concomitant national shortage of injectable penicillin G, results suggest that clinicians should mai
98                  Following administration of penicillin-G, RF stimulation during nonREM sleep evoked
99 e of the amide bond in the benzylpenicillin (penicillin G) side-chain to produce phenylacetic acid an
100                            All compounds but penicillin-G significantly slowed contraction in a dose-
101 ith respect to the microbial inhibition of a penicillin G standard.
102 llular response of Escherichia coli cells to penicillin G-streptomycin and cefazolin.
103 ve form and in complex with penicillin G and penicillin G sulphoxide.
104  complex with the slowly processed substrate penicillin G sulphoxide.
105          For two antibiotics, vancomycin and penicillin G tested at pharmacologic levels, a subset of
106 ll as three clinically relevant antibiotics (penicillin G, tetracycline, ciprofloxacin).
107 gests that during the acylation of PBP 2x by penicillin G the inherent chemical stability of penicill
108                                          For penicillin G, the LOD was 0.16 and LOQ was 0.52 mg kg(-1
109 anges during the enzymatic transformation of Penicillin G to 6-aminopenicillanic acid catalyzed by Pe
110 the use of enhanced intramuscular benzathine penicillin G to supplement intravenous penicillin.
111 tent with JHR within 7 days after benzathine penicillin G treatment.
112                                     Procaine penicillin G was given as 12 h to one-half of the animal
113  one dose of 2.4 million units of benzathine penicillin G was noninferior to treatment with three dos
114 p-49 and Phe-142, mimic interactions made by penicillin G when bound in the active site of TEM-1.
115 49) and Phe(142), mimic interactions made by penicillin G when bound in the beta-lactamase active sit
116 develop chromosomally mediated resistance to penicillin G, which for over 40 years was used to treat
117  markedly diminished the deacylation rate of penicillin G with a minimal impact on acylation, and abo
118 lar injection of 2.4 million U of benzathine penicillin G, with studies reporting 90% to 100% treatme

 
Page Top